The protein mTOR is a central controller of growth and metabolism.
Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer. In the current issue of the journal Proceedings of the National Academy of Sciences, researchers from the Biozentrum of the University of Basel describe how aberrant mTOR signaling in the liver not only affects hepatic metabolism but also whole body physiology.
Activated mTORC1 signaling (top) correlates with increased FGF21 expression (below) in human liver tumor.
University of Basel, Biozentrum
The protein mTOR regulates cell growth and metabolism and thus plays a key role in the development of human disorders. In the cell, this regulatory protein is found in two structurally and functionally distinct protein complexes called mTORC1 and mTORC2. In a recent study, the research group of Prof. Michael Hall from the Biozentrum of the University of Basel has shed light on the role of hepatic mTORC1 in whole body physiology and the relevance for human liver cancers.
Hepatic mTORC1 controls whole body physiology
In mammals, the liver is a key organ that controls whole body physiology in response to nutrients. Hall’s team investigated the role of the nutrient sensor mTORC1 in this process. The researchers were able to show that activation of mTORC1 in the liver of mice reduces not only hepatic lipid metabolism but also locomotor activity and body temperature.
Upon investigating the underlying molecular mechanism, they observed that mTORC1 hyperactivation enhances the level of the stress hormone FGF21 by depletion of the amino acid glutamine. Treatment of animals with glutamine reduced the level of FGF21 and thus prevented the physiological impairments.
Cancer treatment with mTORC1 inhibitors
Human cancers often exhibit aberrant mTORC1 signaling and glutamine addiction. “We were excited to see that in human liver tumors mTORC1 signaling correlates with FGF21 expression”, comments cell biologist Dr. Marion Cornu and first author of the study.
Moreover, mTORC1 inhibitors such as rapamycin are currently used as immunosuppressive agents and anti-cancer drugs. Thus, the novel findings of Hall’s team provide evidence that treatment of glutamine addicted human cancers with rapamycin might have beneficial effects by blocking tumor growth and by preventing deregulation of whole body physiology.
Marion Cornu, Wolfgang Oppliger, Verena Albert, Aaron M. Robitaille, Francesca Trapani, Luca Quagliata, Tobias Fuhrer, Uwe Sauer, Luigi Terracciano, Michael N. Hall
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
PNAS; published online 31 July 2014 | doi: 10.1073/pnas.1412047111
Prof. Michael N. Hall, University of Basel, Biozentrum, phone: +41 61 267 21 50, email: email@example.com
Olivia Poisson | Universität Basel
A 'movie' of ultrafast rotating molecules at a hundred billion per second
06.07.2015 | National Institutes of Natural Sciences
First Comprehensive Analysis of the Woolly Mammoth Genome Completed
06.07.2015 | University of Chicago Medical Center
Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.
The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...
New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions
A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...
Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.
Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...
A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...
The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...
25.06.2015 | Event News
16.06.2015 | Event News
11.06.2015 | Event News
06.07.2015 | Life Sciences
06.07.2015 | Life Sciences
06.07.2015 | Earth Sciences